Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FIG vs MRNA✓SelectedUSD · MRNAFIG vs MRNA performance historyLatest closeAs of-4.68%11/18
Stock and ETF performance explorer

FIG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-85.0%
MRNA return
+530.5%
Excess return
-615.5%
Maximum drawdown
-86.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.7%-4.8%+0.2%-4.5%
7D-8.6%-20.9%+12.2%-7.7%
30D-19.5%-13.3%-6.3%-19.1%
3M-33.4%+212.6%-245.9%-38.6%
6M-28.9%+309.0%-337.9%-37.4%
YTD-53.6%+567.3%-620.9%-63.6%
1Y-52.9%+689.7%-742.5%-64.8%
All-85.0%+530.5%-615.5%-89.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling